Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens

Keyphrases

• Vaccine Adjuvant 100%
• Protein Antigen 100%
• Adjuvant System 100%
• Adjuvant Activity 100%
• Protein Subunit 100%
• Immunogenicity 50%
• Activity Analysis 50%
• Risk-benefit 50%
• Virus 50%
• Vaccination 50%
• Cationic Lipids 50%
• Liposomes 50%
• Liposomal 50%
• Vaccine Development 50%
• Subunit Vaccine 50%
• Lipid-based Formulation 50%
• Delivery System 50%
• Safer Alternatives 50%
• Adverse Reactions 50%
• Particulate 50%
• Immunological Characteristics 50%
• Associated Risk 50%
• Associated Diseases 50%
• Immunomodulator 50%
• High Efficacy 50%
• Innate Immune Recognition 50%
• Novel Adjuvant 50%
• Pharmaceutical Analysis 50%
• Adjuvanted 50%
• Professional Antigen-presenting Cells 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Vaccine Adjuvant 100%
• Adjuvant 100%
• Antigen 100%
• Diseases 75%
• Liposome 50%
• Adverse Event 25%
• Subunit Vaccine 25%
• Immunogenicity 25%
• Immunomodulating Agent 25%

Immunology and Microbiology

• Antigen 100%
• Vaccine Adjuvant 100%
• Adjuvant 100%
• Immunogenicity 25%
• Subunit Vaccine 25%
• Antigen Recognition 25%
• Protein Subunit 25%
• Immunomodulating Drugs 25%
• Antigen-Presenting Cell 25%
• Virus 25%